News

Under the deal, X-Chem will deploy its drug discovery engine, which is based on an ultra-large, high-diversity library in excess of 100 billion molecules, to identify new drug

Under the deal, the two parties will establish scalable processes for manufacturing recombinant adeno-associated viral (rAAV) vector products using current good manufacturing practices (cGMP). The deal will combine

The placebo-controlled, single ascending dose evaluation trial is conducted in Germany and patients from the first cohort have been dosed. The trial, designed to evaluate the safety and

This product is the generic version of Hikma Maple Ltd.’s Robaxin®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug

The findings were presented at the 53rd Annual Meeting of the American College of Neuropsychopharmacology (ACNP) held December 7-11 in Phoenix, Arizona. Dasotraline, a new chemical entity discovered

The multi-year research program will evaluate a novel approach to improve the function of the defective protein associated with cystic fibrosis, called CFTR. The program is investigating a

This product is the generic version of LASTACAFT (alcaftadine ophthalmic solution) 0.25%, which is indicated for the prevention of itching associated with allergic conjunctivitis. Wilshire believes that it

The recall is being initiated as a result of two complaints (one per lot) of particulate matter that was identified as a fragment of the frangible from the

Ovarian cancer patients who have no measurable disease following their initial standard surgery and chemotherapy treatments have an unmet need that may be served by the DPX-Survivac therapy.